An initiative partly funded by the Wellcome Trust Sanger Institute in the UK has moved further towards its goal of producing a 'human cell atlas' (HCA) to map every cell type in the human body.
Developing new medications can take years. But computational biologist Aviv Regev says AI-powered cell mapping is transforming the... How the Human Cell Atlas is fast-tracking new medicines Part 1 of ...
Illumina on Tuesday unveiled what it calls the world’s largest functional cell dictionary that, when paired with artificial ...
Illumina unveiled the Billion Cell Atlas, a large‑scale genetic perturbation dataset built with pharma partners to advance AI‑powered drug discovery, target validation, and disease biology.
Pharmaceutical Technology on MSN
JPM26: Illumina debuts billion cell atlas to drive AI-driven drug discovery
The Billion Cell Atlas, backed by Eli Lilly, MSD and AstraZeneca, maps mechanisms to support informed drug discovery.
The Human Cell Atlas project has delivered a fresh tranche of data mapping fibroblasts in healthy and diseased skin and pointing to drug targets with potential in multiple diseases across a range of ...
Illumina has unveiled a database of genomic alterations, called the Billion Cell Atlas, that can be used to identify and ...
Illumina, Inc. (NASDAQ: ILMN) today introduced the world's largest genome-wide genetic perturbation dataset, being built to ...
A giant functional atlas of immune cells in a Chinese cohort reveals crucial differences with European and Japanese data sets ...
Developing new medications can take years. But computational biologist Aviv Regev says AI-powered cell mapping is transforming the process—helping to create life-saving drugs in much less time. About ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results